Amdocs Limited (NASDAQ:DOX) Increases Dividend to $0.53 Per Share

Amdocs Limited (NASDAQ:DOX - Get Free Report) announced a quarterly dividend on Wednesday, February 5th,Wall Street Journal reports. Stockholders of record on Monday, March 31st will be given a dividend of 0.527 per share by the technology company on Sunday, April 20th. This represents a $2.11 annualized dividend and a dividend yield of 2.45%. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs's previous quarterly dividend of $0.48.

Amdocs has increased its dividend by an average of 10.0% per year over the last three years. Amdocs has a payout ratio of 27.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect Amdocs to earn $6.75 per share next year, which means the company should continue to be able to cover its $2.11 annual dividend with an expected future payout ratio of 31.3%.

Amdocs Trading Up 0.0 %

Shares of NASDAQ:DOX traded up $0.01 during midday trading on Friday, reaching $85.97. The company's stock had a trading volume of 671,265 shares, compared to its average volume of 632,452. The firm has a market cap of $9.71 billion, a price-to-earnings ratio of 19.95, a price-to-earnings-growth ratio of 1.41 and a beta of 0.71. Amdocs has a 1 year low of $74.41 and a 1 year high of $94.04. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $85.94 and a 200 day moving average price of $86.45.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. Research analysts forecast that Amdocs will post 6.21 EPS for the current year.

Analyst Ratings Changes

DOX has been the topic of several analyst reports. StockNews.com raised shares of Amdocs from a "buy" rating to a "strong-buy" rating in a research note on Wednesday. Barclays dropped their target price on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a research report on Thursday, November 14th. Finally, Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $101.20.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.